Global Pharmacokinetics Services Market Size, Status And Forecast 2021-2027

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Small Molecules Pharmacokinetics Services
1.2.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Pharmacokinetics Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Small & Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmacokinetics Services Market Perspective (2016-2027)
2.2 Pharmacokinetics Services Growth Trends by Regions
2.2.1 Pharmacokinetics Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmacokinetics Services Historic Market Share by Regions (2016-2021)
2.2.3 Pharmacokinetics Services Forecasted Market Size by Regions (2022-2027)
2.3 Pharmacokinetics Services Industry Dynamic
2.3.1 Pharmacokinetics Services Market Trends
2.3.2 Pharmacokinetics Services Market Drivers
2.3.3 Pharmacokinetics Services Market Challenges
2.3.4 Pharmacokinetics Services Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Services Players by Revenue
3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2016-2021)
3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2016-2021)
3.2 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
3.4 Global Pharmacokinetics Services Market Concentration Ratio
3.4.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2020
3.5 Pharmacokinetics Services Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Services Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Services Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacokinetics Services Breakdown Data by Type
4.1 Global Pharmacokinetics Services Historic Market Size by Type (2016-2021)
4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2022-2027)

5 Pharmacokinetics Services Breakdown Data by Application
5.1 Global Pharmacokinetics Services Historic Market Size by Application (2016-2021)
5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharmacokinetics Services Market Size (2016-2027)
6.2 North America Pharmacokinetics Services Market Size by Type
6.2.1 North America Pharmacokinetics Services Market Size by Type (2016-2021)
6.2.2 North America Pharmacokinetics Services Market Size by Type (2022-2027)
6.2.3 North America Pharmacokinetics Services Market Size by Type (2016-2027)
6.3 North America Pharmacokinetics Services Market Size by Application
6.3.1 North America Pharmacokinetics Services Market Size by Application (2016-2021)
6.3.2 North America Pharmacokinetics Services Market Size by Application (2022-2027)
6.3.3 North America Pharmacokinetics Services Market Size by Application (2016-2027)
6.4 North America Pharmacokinetics Services Market Size by Country
6.4.1 North America Pharmacokinetics Services Market Size by Country (2016-2021)
6.4.2 North America Pharmacokinetics Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pharmacokinetics Services Market Size (2016-2027)
7.2 Europe Pharmacokinetics Services Market Size by Type
7.2.1 Europe Pharmacokinetics Services Market Size by Type (2016-2021)
7.2.2 Europe Pharmacokinetics Services Market Size by Type (2022-2027)
7.2.3 Europe Pharmacokinetics Services Market Size by Type (2016-2027)
7.3 Europe Pharmacokinetics Services Market Size by Application
7.3.1 Europe Pharmacokinetics Services Market Size by Application (2016-2021)
7.3.2 Europe Pharmacokinetics Services Market Size by Application (2022-2027)
7.3.3 Europe Pharmacokinetics Services Market Size by Application (2016-2027)
7.4 Europe Pharmacokinetics Services Market Size by Country
7.4.1 Europe Pharmacokinetics Services Market Size by Country (2016-2021)
7.4.2 Europe Pharmacokinetics Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Services Market Size (2016-2027)
8.2 Asia-Pacific Pharmacokinetics Services Market Size by Type
8.2.1 Asia-Pacific Pharmacokinetics Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmacokinetics Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmacokinetics Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmacokinetics Services Market Size by Application
8.3.1 Asia-Pacific Pharmacokinetics Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmacokinetics Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmacokinetics Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmacokinetics Services Market Size by Region
8.4.1 Asia-Pacific Pharmacokinetics Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmacokinetics Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharmacokinetics Services Market Size (2016-2027)
9.2 Latin America Pharmacokinetics Services Market Size by Type
9.2.1 Latin America Pharmacokinetics Services Market Size by Type (2016-2021)
9.2.2 Latin America Pharmacokinetics Services Market Size by Type (2022-2027)
9.2.3 Latin America Pharmacokinetics Services Market Size by Type (2016-2027)
9.3 Latin America Pharmacokinetics Services Market Size by Application
9.3.1 Latin America Pharmacokinetics Services Market Size by Application (2016-2021)
9.3.2 Latin America Pharmacokinetics Services Market Size by Application (2022-2027)
9.3.3 Latin America Pharmacokinetics Services Market Size by Application (2016-2027)
9.4 Latin America Pharmacokinetics Services Market Size by Country
9.4.1 Latin America Pharmacokinetics Services Market Size by Country (2016-2021)
9.4.2 Latin America Pharmacokinetics Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Services Market Size (2016-2027)
10.2 Middle East & Africa Pharmacokinetics Services Market Size by Type
10.2.1 Middle East & Africa Pharmacokinetics Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmacokinetics Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmacokinetics Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmacokinetics Services Market Size by Application
10.3.1 Middle East & Africa Pharmacokinetics Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmacokinetics Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmacokinetics Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmacokinetics Services Market Size by Country
10.4.1 Middle East & Africa Pharmacokinetics Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmacokinetics Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Evotec AG (Germany)
11.1.1 Evotec AG (Germany) Company Details
11.1.2 Evotec AG (Germany) Business Overview
11.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
11.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2016-2021)
11.1.5 Evotec AG (Germany) Recent Development
11.2 Pacific BioLabs (US)
11.2.1 Pacific BioLabs (US) Company Details
11.2.2 Pacific BioLabs (US) Business Overview
11.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
11.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2016-2021)
11.2.5 Pacific BioLabs (US) Recent Development
11.3 GVK Biosciences Private Limited (India)
11.3.1 GVK Biosciences Private Limited (India) Company Details
11.3.2 GVK Biosciences Private Limited (India) Business Overview
11.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
11.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2016-2021)
11.3.5 GVK Biosciences Private Limited (India) Recent Development
11.4 Shanghai Medicilon Inc. (China)
11.4.1 Shanghai Medicilon Inc. (China) Company Details
11.4.2 Shanghai Medicilon Inc. (China) Business Overview
11.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
11.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2016-2021)
11.4.5 Shanghai Medicilon Inc. (China) Recent Development
11.5 Pharmaceutical Product Development, LLC (US)
11.5.1 Pharmaceutical Product Development, LLC (US) Company Details
11.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
11.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
11.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2016-2021)
11.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
11.6 Charles River Laboratories International, Inc. (US)
11.6.1 Charles River Laboratories International, Inc. (US) Company Details
11.6.2 Charles River Laboratories International, Inc. (US) Business Overview
11.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
11.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2016-2021)
11.6.5 Charles River Laboratories International, Inc. (US) Recent Development
11.7 PAREXEL International Corporation (US)
11.7.1 PAREXEL International Corporation (US) Company Details
11.7.2 PAREXEL International Corporation (US) Business Overview
11.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
11.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2016-2021)
11.7.5 PAREXEL International Corporation (US) Recent Development
11.8 Eurofins Scientific, Inc. (Luxembourg)
11.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Details
11.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
11.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
11.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2016-2021)
11.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
11.9 Frontage Labs (US)
11.9.1 Frontage Labs (US) Company Details
11.9.2 Frontage Labs (US) Business Overview
11.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
11.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2016-2021)
11.9.5 Frontage Labs (US) Recent Development
11.10 SGS SA (Switzerland)
11.10.1 SGS SA (Switzerland) Company Details
11.10.2 SGS SA (Switzerland) Business Overview
11.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
11.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2016-2021)
11.10.5 SGS SA (Switzerland) Recent Development
11.11 LGC Limited (UK)
11.11.1 LGC Limited (UK) Company Details
11.11.2 LGC Limited (UK) Business Overview
11.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
11.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2016-2021)
11.11.5 LGC Limited (UK) Recent Development
11.12 Creative Bioarray (US)
11.12.1 Creative Bioarray (US) Company Details
11.12.2 Creative Bioarray (US) Business Overview
11.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
11.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2016-2021)
11.12.5 Creative Bioarray (US) Recent Development
11.13 Certara, L.P. (Germany)
11.13.1 Certara, L.P. (Germany) Company Details
11.13.2 Certara, L.P. (Germany) Business Overview
11.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
11.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2016-2021)
11.13.5 Certara, L.P. (Germany) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharmacokinetics Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Small Molecules Pharmacokinetics Services
Table 3. Key Players of Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Table 4. Global Pharmacokinetics Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharmacokinetics Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmacokinetics Services Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharmacokinetics Services Market Share by Regions (2016-2021)
Table 8. Global Pharmacokinetics Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharmacokinetics Services Market Share by Regions (2022-2027)
Table 10. Pharmacokinetics Services Market Trends
Table 11. Pharmacokinetics Services Market Drivers
Table 12. Pharmacokinetics Services Market Challenges
Table 13. Pharmacokinetics Services Market Restraints
Table 14. Global Pharmacokinetics Services Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharmacokinetics Services Market Share by Players (2016-2021)
Table 16. Global Top Pharmacokinetics Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics Services as of 2020)
Table 17. Ranking of Global Top Pharmacokinetics Services Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharmacokinetics Services Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacokinetics Services Product Solution and Service
Table 21. Date of Enter into Pharmacokinetics Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacokinetics Services Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharmacokinetics Services Revenue Market Share by Type (2016-2021)
Table 25. Global Pharmacokinetics Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharmacokinetics Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharmacokinetics Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharmacokinetics Services Revenue Market Share by Application (2016-2021)
Table 29. Global Pharmacokinetics Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharmacokinetics Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharmacokinetics Services Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharmacokinetics Services Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharmacokinetics Services Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharmacokinetics Services Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharmacokinetics Services Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharmacokinetics Services Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharmacokinetics Services Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharmacokinetics Services Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharmacokinetics Services Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharmacokinetics Services Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharmacokinetics Services Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharmacokinetics Services Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharmacokinetics Services Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharmacokinetics Services Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmacokinetics Services Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmacokinetics Services Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmacokinetics Services Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharmacokinetics Services Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharmacokinetics Services Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharmacokinetics Services Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharmacokinetics Services Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharmacokinetics Services Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharmacokinetics Services Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharmacokinetics Services Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharmacokinetics Services Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharmacokinetics Services Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmacokinetics Services Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmacokinetics Services Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmacokinetics Services Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharmacokinetics Services Market Size by Country (2022-2027) & (US$ Million)
Table 61. Evotec AG (Germany) Company Details
Table 62. Evotec AG (Germany) Business Overview
Table 63. Evotec AG (Germany) Pharmacokinetics Services Product
Table 64. Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 65. Evotec AG (Germany) Recent Development
Table 66. Pacific BioLabs (US) Company Details
Table 67. Pacific BioLabs (US) Business Overview
Table 68. Pacific BioLabs (US) Pharmacokinetics Services Product
Table 69. Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 70. Pacific BioLabs (US) Recent Development
Table 71. GVK Biosciences Private Limited (India) Company Details
Table 72. GVK Biosciences Private Limited (India) Business Overview
Table 73. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product
Table 74. GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 75. GVK Biosciences Private Limited (India) Recent Development
Table 76. Shanghai Medicilon Inc. (China) Company Details
Table 77. Shanghai Medicilon Inc. (China) Business Overview
Table 78. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product
Table 79. Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 80. Shanghai Medicilon Inc. (China) Recent Development
Table 81. Pharmaceutical Product Development, LLC (US) Company Details
Table 82. Pharmaceutical Product Development, LLC (US) Business Overview
Table 83. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product
Table 84. Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 85. Pharmaceutical Product Development, LLC (US) Recent Development
Table 86. Charles River Laboratories International, Inc. (US) Company Details
Table 87. Charles River Laboratories International, Inc. (US) Business Overview
Table 88. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product
Table 89. Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 90. Charles River Laboratories International, Inc. (US) Recent Development
Table 91. PAREXEL International Corporation (US) Company Details
Table 92. PAREXEL International Corporation (US) Business Overview
Table 93. PAREXEL International Corporation (US) Pharmacokinetics Services Product
Table 94. PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 95. PAREXEL International Corporation (US) Recent Development
Table 96. Eurofins Scientific, Inc. (Luxembourg) Company Details
Table 97. Eurofins Scientific, Inc. (Luxembourg) Business Overview
Table 98. Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 99. Eurofins Scientific, Inc. (Luxembourg) Recent Development
Table 100. Frontage Labs (US) Company Details
Table 101. Frontage Labs (US) Business Overview
Table 102. Frontage Labs (US) Pharmacokinetics Services Product
Table 103. Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 104. Frontage Labs (US) Recent Development
Table 105. SGS SA (Switzerland) Company Details
Table 106. SGS SA (Switzerland) Business Overview
Table 107. SGS SA (Switzerland) Pharmacokinetics Services Product
Table 108. SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 109. SGS SA (Switzerland) Recent Development
Table 110. LGC Limited (UK) Company Details
Table 111. LGC Limited (UK) Business Overview
Table 112. LGC Limited (UK) Pharmacokinetics Services Product
Table 113. LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 114. LGC Limited (UK) Recent Development
Table 115. Creative Bioarray (US) Company Details
Table 116. Creative Bioarray (US) Business Overview
Table 117. Creative Bioarray (US) Pharmacokinetics Services Product
Table 118. Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 119. Creative Bioarray (US) Recent Development
Table 120. Certara, L.P. (Germany) Company Details
Table 121. Certara, L.P. (Germany) Business Overview
Table 122. Certara, L.P. (Germany) Pharmacokinetics Services Product
Table 123. Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2016-2021) & (US$ Million)
Table 124. Certara, L.P. (Germany) Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacokinetics Services Market Share by Type: 2020 VS 2027
Figure 2. Small Molecules Pharmacokinetics Services Features
Figure 3. Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Features
Figure 4. Global Pharmacokinetics Services Market Share by Application: 2020 VS 2027
Figure 5. Small & Medium Enterprise Case Studies
Figure 6. Large Enterprise Case Studies
Figure 7. Pharmacokinetics Services Report Years Considered
Figure 8. Global Pharmacokinetics Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Pharmacokinetics Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Pharmacokinetics Services Market Share by Regions: 2020 VS 2027
Figure 11. Global Pharmacokinetics Services Market Share by Regions (2022-2027)
Figure 12. Global Pharmacokinetics Services Market Share by Players in 2020
Figure 13. Global Top Pharmacokinetics Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics Services as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Pharmacokinetics Services Revenue in 2020
Figure 15. Global Pharmacokinetics Services Revenue Market Share by Type (2016-2021)
Figure 16. Global Pharmacokinetics Services Revenue Market Share by Type (2022-2027)
Figure 17. North America Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Pharmacokinetics Services Market Share by Type (2016-2027)
Figure 19. North America Pharmacokinetics Services Market Share by Application (2016-2027)
Figure 20. North America Pharmacokinetics Services Market Share by Country (2016-2027)
Figure 21. United States Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharmacokinetics Services Market Share by Type (2016-2027)
Figure 25. Europe Pharmacokinetics Services Market Share by Application (2016-2027)
Figure 26. Europe Pharmacokinetics Services Market Share by Country (2016-2027)
Figure 27. Germany Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharmacokinetics Services Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Pharmacokinetics Services Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Pharmacokinetics Services Market Share by Region (2016-2027)
Figure 37. China Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharmacokinetics Services Market Share by Type (2016-2027)
Figure 45. Latin America Pharmacokinetics Services Market Share by Application (2016-2027)
Figure 46. Latin America Pharmacokinetics Services Market Share by Country (2016-2027)
Figure 47. Mexico Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharmacokinetics Services Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Pharmacokinetics Services Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Pharmacokinetics Services Market Share by Country (2016-2027)
Figure 53. Turkey Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Pharmacokinetics Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Evotec AG (Germany) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 57. Pacific BioLabs (US) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 58. GVK Biosciences Private Limited (India) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 59. Shanghai Medicilon Inc. (China) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 60. Pharmaceutical Product Development, LLC (US) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 61. Charles River Laboratories International, Inc. (US) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 62. PAREXEL International Corporation (US) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 63. Eurofins Scientific, Inc. (Luxembourg) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 64. Frontage Labs (US) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 65. SGS SA (Switzerland) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 66. LGC Limited (UK) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 67. Creative Bioarray (US) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 68. Certara, L.P. (Germany) Revenue Growth Rate in Pharmacokinetics Services Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.